Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C4H7Cl3O |
| Molecular Weight | 177.457 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(O)C(Cl)(Cl)Cl
InChI
InChIKey=OSASVXMJTNOKOY-UHFFFAOYSA-N
InChI=1S/C4H7Cl3O/c1-3(2,8)4(5,6)7/h8H,1-2H3
| Molecular Formula | C4H7Cl3O |
| Molecular Weight | 177.457 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Chlorobutanol, or trichloro-2-methyl-2-propanol, is an analgesic and sedative hypnotic in man, and an experimental general anesthetic. It has antibacterial and antifungal properties. It is also used chemical preservative for parenteral drugs. It was found, that chlorobutanol inhibited mammalian Nav 1.2 channels at concentrations less than those used to preserve parenteral solutions. Its mechanism of inhibiting Na channels differs from that of local anesthetics in that it does not show use dependent or state dependent inhibition.
Approval Year
T1/2
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
10 day EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/7159691 |
600 mg single, oral dose: 600 mg route of administration: Oral experiment type: SINGLE co-administered: |
CHLOROBUTANOL plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FASTED |
Funbound
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
43% EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/7159691 |
600 mg single, oral dose: 600 mg route of administration: Oral experiment type: SINGLE co-administered: |
CHLOROBUTANOL plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FASTED |
Doses
| Dose | Population | Adverse events |
|---|---|---|
600 mg single, oral Studied dose |
healthy, 20-30 |
Other AEs: Sedation, Light headedness... |
AEs
| AE | Significance | Dose | Population |
|---|---|---|---|
| Euphoria | 600 mg single, oral Studied dose |
healthy, 20-30 |
|
| Light headedness | 600 mg single, oral Studied dose |
healthy, 20-30 |
|
| Sedation | 600 mg single, oral Studied dose |
healthy, 20-30 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| [Chlorobutanol poisoning: about a case]. | 2010-10 |
|
| Cytotoxicity of five fluoroquinolone and two nonsteroidal anti-inflammatory benzalkonium chloride-free ophthalmic solutions in four corneoconjunctival cell lines. | 2010-09-20 |
|
| Efficacy and patient tolerability of travoprost BAK-free solution in patients with open-angle glaucoma and ocular hypertension. | 2010-08-09 |
|
| High gene expression of inflammatory markers and IL-17A correlates with severity of injection site reactions of Atlantic salmon vaccinated with oil-adjuvanted vaccines. | 2010-05-27 |
|
| The world's richest tadpole communities show functional redundancy and low functional diversity: ecological data on Madagascar's stream-dwelling amphibian larvae. | 2010-05-12 |
|
| Interactions at human ether-à-go-go-related gene channels. | 2010-04 |
|
| Modification of cell wall properties in lettuce improves shelf life. | 2010-02 |
|
| Evaluation of acute corneal barrier change induced by topically applied preservatives using corneal transepithelial electric resistance in vivo. | 2010-01 |
|
| Evidence that phosphatidylinositol 3-kinase is involved in sperm-induced tyrosine kinase signaling in Xenopus egg fertilization. | 2009-12-17 |
|
| Therapeutic approaches to cerebral vasospasm complicating ruptured aneurysm. | 2009-11-16 |
|
| Allergy to ophthalmic preservatives. | 2009-10 |
|
| Randomized, placebo-controlled evaluation of chlorobutanol, potassium carbonate, and irrigation in cerumen removal. | 2009-08 |
|
| Methadone-associated Q-T interval prolongation and torsades de pointes. | 2009-05-01 |
|
| A Freshwater clam (Corbicula fluminea) extract reduces cholesterol level and hepatic lipids in normal rats and xenobiotics-induced hypercholesterolemic rats. | 2009-04-22 |
|
| In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays: the enhancing effect of potassium sorbate. | 2009-04-11 |
|
| GC determination of acetone, acetaldehyde, ethanol, and methanol in biological matrices and cell culture. | 2009-04 |
|
| Reichardt's dye and its reactions with the alkylating agents 4-chloro-1-butanol, ethyl methanesulfonate, 1-bromobutane and Fast Red B - a potentially useful reagent for the detection of genotoxic impurities in pharmaceuticals. | 2009-04 |
|
| Comparative toxicity of preservatives on immortalized corneal and conjunctival epithelial cells. | 2009-04 |
|
| Atlantic salmon eggs favour sperm in competition that have similar major histocompatibility alleles. | 2009-02-07 |
|
| Minimally invasive strabismus surgery (MISS) for inferior obliquus recession. | 2009-02 |
|
| Regeneration of the radial nerve cord in the sea cucumber Holothuria glaberrima. | 2009-01-06 |
|
| Ocular preservatives: associated risks and newer options. | 2009 |
|
| Minimally invasive strabismus surgery for horizontal rectus muscle reoperations. | 2008-12 |
|
| DNA damage in preserved specimens and tissue samples: a molecular assessment. | 2008-10-23 |
|
| Cytotoxicity of ophthalmic solutions with and without preservatives to human corneal endothelial cells, epithelial cells and conjunctival epithelial cells. | 2008-08 |
|
| [Efficacy of an antiseptic dialysis of purulent wounds in the dentofacial region with hyvalix]. | 2008-04-18 |
|
| Ototoxicity of triethanolamine polypeptide (cerumenex) in the chinchilla. | 2008-03 |
|
| Development and evaluation of a chloramphenicol hypertonic ophthalmic solution. | 2008-01 |
|
| Common cellular events occur during wound healing and organ regeneration in the sea cucumber Holothuria glaberrima. | 2007-10-18 |
|
| Equimolar mixture of 2,2,2-trifluoroethanol and 4-chloro-1-butanol is a stronger inducer of molten globule state: isothermal titration calorimetric and spectroscopic studies. | 2007-10 |
|
| [The treatment of hyperemesis gravidarum with chlorobutanol-caffeine rectal suppositories in Denmark: practice and evidence]. | 2007-05-28 |
|
| Medication administered to children from 0 to 7.5 years in the Avon Longitudinal Study of Parents and Children (ALSPAC). | 2007-02 |
|
| Development and validation of a stability-indicating analytical method for the quantitation of oxytocin in pharmaceutical dosage forms. | 2007-01-04 |
|
| [Contact allergy to triethanolamine in ear drops and shampoo]. | 2007-01 |
|
| Vitamin C. Biosynthesis, recycling and degradation in mammals. | 2007-01 |
|
| Conjunctival provocation test for the diagnosis of ocular hypersensitivity to chlorobutanol. | 2007-01 |
|
| Effect of ophthalmic solution components on acrylic intraocular lenses. | 2007-01 |
|
| Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhage. | 2007 |
|
| Are multidose over-the-counter artificial tears adequately preserved? | 2006-05 |
|
| Glucuronate, the precursor of vitamin C, is directly formed from UDP-glucuronate in liver. | 2006-04 |
|
| An efficient synthesis of a dual PPAR alpha/gamma agonist and the formation of a sterically congested alpha-aryloxyisobutyric acid via a Bargellini reaction. | 2005-10-14 |
|
| Cerumen removal products. | 2005-10-06 |
|
| Preventing exposure keratopathy in the critically ill: a prospective study comparing eye care regimes. | 2005-08 |
|
| Allergic contact dermatitis from triethanolamine polypeptide oleate condensate in eardrops and shampoo. | 2005-04 |
|
| Application of a capillary electrophoresis method for simultaneous determination of preservatives in pharmaceutical formulations. | 2005-02 |
|
| Assessment of corneal epitheliopathy in the critically ill. | 2005-02 |
|
| Neurotoxicity of intra-arterial papaverine preserved with chlorobutanol used for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. | 2004-11 |
|
| Randomized, placebo-controlled evaluation of Cerumenex and Murine earwax removal products. | 2004-10 |
|
| Chronic tinnitus resulting from cerumen removal procedures. | 2004 |
|
| Is ketamine or its preservative responsible for neurotoxicity in the rabbit? | 1993-01 |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7689400
It was examined chlorobutanol effect on on exocrine response and intracellular Ca2+ dynamics in isolated pancreatic acini of the rat. Chlorobutanol (1 mg ml-1) markedly inhibited the secretory response to cholecystokinin octapeptide (CCK-8), carbamylcholine chloride (carbachol), or sodium fluoride, a direct G-protein activator. However, chlorobutanol itself induced a maximal release of amylase when the dose was increased to 4 mg ml-1. Chlorobutanol inhibited 13 pM [125I]-CCK-8 or 0.5 nM [3H]-methylscopolamine chloride binding to the acinar cells in a dose-dependent manner. These results indicate that chlorobutanol produces discernible pharmacological effects on the secretory response in rat pancreatic acinar cells through changes in the Ca2+ dynamics.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:15:22 GMT 2025
by
admin
on
Mon Mar 31 18:15:22 GMT 2025
|
| Record UNII |
HM4YQM8WRC
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
98896
Created by
admin on Mon Mar 31 18:15:22 GMT 2025 , Edited by admin on Mon Mar 31 18:15:22 GMT 2025
|
||
|
WHO-ATC |
A04AD54
Created by
admin on Mon Mar 31 18:15:22 GMT 2025 , Edited by admin on Mon Mar 31 18:15:22 GMT 2025
|
||
|
EPA PESTICIDE CODE |
17501
Created by
admin on Mon Mar 31 18:15:22 GMT 2025 , Edited by admin on Mon Mar 31 18:15:22 GMT 2025
|
||
|
CFR |
21 CFR 310.538
Created by
admin on Mon Mar 31 18:15:22 GMT 2025 , Edited by admin on Mon Mar 31 18:15:22 GMT 2025
|
||
|
WHO-VATC |
QA04AD54
Created by
admin on Mon Mar 31 18:15:22 GMT 2025 , Edited by admin on Mon Mar 31 18:15:22 GMT 2025
|
||
|
WHO-VATC |
QA04AD04
Created by
admin on Mon Mar 31 18:15:22 GMT 2025 , Edited by admin on Mon Mar 31 18:15:22 GMT 2025
|
||
|
WHO-ATC |
A04AD04
Created by
admin on Mon Mar 31 18:15:22 GMT 2025 , Edited by admin on Mon Mar 31 18:15:22 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
440
Created by
admin on Mon Mar 31 18:15:22 GMT 2025 , Edited by admin on Mon Mar 31 18:15:22 GMT 2025
|
PRIMARY | |||
|
HM4YQM8WRC
Created by
admin on Mon Mar 31 18:15:22 GMT 2025 , Edited by admin on Mon Mar 31 18:15:22 GMT 2025
|
PRIMARY | |||
|
100000081866
Created by
admin on Mon Mar 31 18:15:22 GMT 2025 , Edited by admin on Mon Mar 31 18:15:22 GMT 2025
|
PRIMARY | |||
|
C45678
Created by
admin on Mon Mar 31 18:15:22 GMT 2025 , Edited by admin on Mon Mar 31 18:15:22 GMT 2025
|
CONCEPT | Industrial Aid | ||
|
3092
Created by
admin on Mon Mar 31 18:15:22 GMT 2025 , Edited by admin on Mon Mar 31 18:15:22 GMT 2025
|
PRIMARY | |||
|
C65317
Created by
admin on Mon Mar 31 18:15:22 GMT 2025 , Edited by admin on Mon Mar 31 18:15:22 GMT 2025
|
PRIMARY | |||
|
44794
Created by
admin on Mon Mar 31 18:15:22 GMT 2025 , Edited by admin on Mon Mar 31 18:15:22 GMT 2025
|
PRIMARY | |||
|
SUB11813MIG
Created by
admin on Mon Mar 31 18:15:22 GMT 2025 , Edited by admin on Mon Mar 31 18:15:22 GMT 2025
|
PRIMARY | |||
|
CHEMBL1439973
Created by
admin on Mon Mar 31 18:15:22 GMT 2025 , Edited by admin on Mon Mar 31 18:15:22 GMT 2025
|
PRIMARY | |||
|
2761
Created by
admin on Mon Mar 31 18:15:22 GMT 2025 , Edited by admin on Mon Mar 31 18:15:22 GMT 2025
|
PRIMARY | |||
|
CHLOROBUTANOL
Created by
admin on Mon Mar 31 18:15:22 GMT 2025 , Edited by admin on Mon Mar 31 18:15:22 GMT 2025
|
PRIMARY | Description: Colourless crystals or a white, crystalline powder; odour, characteristic, camphoraceous.Solubility: Slightly soluble in water; very soluble in ethanol (~750 g/l) TS and ether R; soluble in glycerol R.Category: Antimicrobial preservative.Storage: Chlorobutanol should be kept in a tightly closed container. | ||
|
200-317-6
Created by
admin on Mon Mar 31 18:15:22 GMT 2025 , Edited by admin on Mon Mar 31 18:15:22 GMT 2025
|
PRIMARY | |||
|
5977
Created by
admin on Mon Mar 31 18:15:22 GMT 2025 , Edited by admin on Mon Mar 31 18:15:22 GMT 2025
|
PRIMARY | |||
|
DB11386
Created by
admin on Mon Mar 31 18:15:22 GMT 2025 , Edited by admin on Mon Mar 31 18:15:22 GMT 2025
|
PRIMARY | |||
|
57-15-8
Created by
admin on Mon Mar 31 18:15:22 GMT 2025 , Edited by admin on Mon Mar 31 18:15:22 GMT 2025
|
PRIMARY | |||
|
1112503
Created by
admin on Mon Mar 31 18:15:22 GMT 2025 , Edited by admin on Mon Mar 31 18:15:22 GMT 2025
|
PRIMARY | |||
|
D002724
Created by
admin on Mon Mar 31 18:15:22 GMT 2025 , Edited by admin on Mon Mar 31 18:15:22 GMT 2025
|
PRIMARY | |||
|
SUB06190MIG
Created by
admin on Mon Mar 31 18:15:22 GMT 2025 , Edited by admin on Mon Mar 31 18:15:22 GMT 2025
|
PRIMARY | |||
|
DTXSID1041217
Created by
admin on Mon Mar 31 18:15:22 GMT 2025 , Edited by admin on Mon Mar 31 18:15:22 GMT 2025
|
PRIMARY | |||
|
CHLOROBUTANOL
Created by
admin on Mon Mar 31 18:15:22 GMT 2025 , Edited by admin on Mon Mar 31 18:15:22 GMT 2025
|
PRIMARY | |||
|
m3399
Created by
admin on Mon Mar 31 18:15:22 GMT 2025 , Edited by admin on Mon Mar 31 18:15:22 GMT 2025
|
PRIMARY | Merck Index | ||
|
2378
Created by
admin on Mon Mar 31 18:15:22 GMT 2025 , Edited by admin on Mon Mar 31 18:15:22 GMT 2025
|
PRIMARY | RxNorm | ||
|
HM4YQM8WRC
Created by
admin on Mon Mar 31 18:15:22 GMT 2025 , Edited by admin on Mon Mar 31 18:15:22 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
|
||
|
SOLVATE->ANHYDROUS |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
IMPURITY -> PARENT |
|
||
|
|
IMPURITY -> PARENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|